Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Supernus Pharmaceuticals Inc

+ Add to Watchlist


13.2000 USD 0.2400 1.79%

As of 20:10:00 ET on 05/26/2015.

Company Profile for Supernus Pharmaceuticals Inc (SUPN)

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.

Contact Information

Supernus Pharmaceuticals Inc

1550 East Gude Drive
Rockville, MD 20850
United States
Phone: 1-301-838-2500
Fax: 1-301-424-1364

Key Executives for Supernus Pharmaceuticals Inc (SUPN)

Jack A KhattarPresident/CEO/Secy/FounderStefan K F SchwabeExec VP:Rsch & Dev
Padmanabh P BhattSenior VP:Intellectual PropertyVictor L VaughnSenior VP:Sales & Mktg
Gregory S PatrickVP/CFO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil